Cargando…
Fenfluramine: New Treatment for Seizures in Dravet Syndrome
Investigators for the FAiRE DS Study Group assessed the efficacy and safety of Fenfluramine for treating seizures in patients less than 18 y.o. with Dravet Syndrome in an international double-blind, placebo-controlled clinical trial. A total of 119 patients (mean age 9.0 y, 54% male) were enrolled i...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pediatric Neurology Briefs Publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071945/ https://www.ncbi.nlm.nih.gov/pubmed/32189958 http://dx.doi.org/10.15844/pedneurbriefs-34-8 |